{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:12:32Z","timestamp":1794366752324,"version":"4.9.0"},"reference-count":33,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>This study aims to compare whether the use of a salivary substitute including an enzymatic system clinically reduces the intensity of xerostomia, as well as exploring the impact that this has on the quality of life, in patients who had received radiotherapy in the head and neck (HNC) region. Forty patients who had completed radiotherapy treatment within 6 months to 1 year previously were allocated into an Enzymatic Spray group (n = 21) or a Placebo arm (n = 19). It should be noted that two patients in the Placebo arm declined to participate during phase 2 of the study. All patients were randomized and used both products three times a day for 30 days. For analysis, xerostomia grade, unstimulated (UWS) and stimulated (SWS) salivary flow rate, and quality of life through the University of Washington Quality of Life Questionnaire validated in Portuguese (UW-QoL) were assessed in two phases: Phase 1 (before the use of the products) and Phase 2 (after 30 days of using the products). All clinical data were collected from medical records. Analyzing the salivary substitute with the enzymatic system, an improvement in xerostomia complaints was observed 30 days after using the product; however, this difference was not statistically significant (p &gt; 0.05). Regarding quality of life, no significant differences were observed in relation to the UW-QoL and saliva domain between the groups in the two phases of the study (p &gt; 0.05). The salivary substitute with the enzymatic system may be effective in reducing radio-induced xerostomia symptoms; however, further research is necessary to evaluate the efficacy of this salivary substitute on oral health.<\/jats:p>","DOI":"10.3390\/curroncol31020082","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T08:43:48Z","timestamp":1708505028000},"page":"1102-1112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region"],"prefix":"10.3390","volume":"31","author":[{"given":"Let\u00edcia Pacheco","family":"Porangaba","sequence":"first","affiliation":[{"name":"Stomatology Department, A.C. Camargo Cancer Center, S\u00e3o Paulo 01509-010, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio","family":"de Melo Garcia","sequence":"additional","affiliation":[{"name":"Stomatology Department, A.C. Camargo Cancer Center, S\u00e3o Paulo 01509-010, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Alvarenga Antonio","family":"Rabelo","sequence":"additional","affiliation":[{"name":"Pradel Pharmacy, S\u00e3o Paulo 05592-140, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Puche","family":"Andrade","sequence":"additional","affiliation":[{"name":"Pradel Pharmacy, S\u00e3o Paulo 05592-140, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-1536","authenticated-orcid":false,"given":"Fabio","family":"de Abreu Alves","sequence":"additional","affiliation":[{"name":"Stomatology Department, A.C. Camargo Cancer Center, S\u00e3o Paulo 01509-010, Brazil"},{"name":"Stomatology Department, School of Dentistry, S\u00e3o Paulo University, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-5545","authenticated-orcid":false,"given":"Antonio C\u00e1ssio Assis","family":"Pellizzon","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, A.C. Camargo Cancer Center, S\u00e3o Paulo 01509-010, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella Chagas","family":"Jaguar","sequence":"additional","affiliation":[{"name":"Stomatology Department, A.C. Camargo Cancer Center, S\u00e3o Paulo 01509-010, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","article-title":"Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment","volume":"91","author":"Marur","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-3-319-65421-8_10","article-title":"Perspectives in Head and Neck Medical Oncology","volume":"174","author":"Amanam","year":"2018","journal-title":"Cancer Treat Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hed.20045","article-title":"Radiation-induced Xerostomia in patients with head and neck cancer: Pathogenesis, impact on quality of life, and management","volume":"26","author":"Chambers","year":"2004","journal-title":"Head Neck"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/cncr.22302","article-title":"Radiation-induced xerostomia in patients with head and neck cancer","volume":"107","author":"Dirix","year":"2006","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/idh.12348","article-title":"Mucosal microflora in head and neck cancer patients","volume":"16","author":"Finizia","year":"2018","journal-title":"Int. J. Dent. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/cam4.1221","article-title":"Common oral complications of head and neck cancer radiation therapy: Mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis","volume":"6","author":"Sroussi","year":"2017","journal-title":"Cancer Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Butera, A., Gallo, S., Pascadopoli, M., Montasser, M.A., Abd El Latief, M.H., Modica, G.G., and Scribante, A. (2022). Home Oral Care with Biomimetic Hydroxyapatite vs. Conventional Fluoridated Toothpaste for the Remineralization and Desensitizing of White Spot Lesions: Randomized Clinical Trial. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19148676"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.oraloncology.2016.12.031","article-title":"Interventions for the management of radiotherapy-induced xerostomia and hyposalivation: A systematic review and meta-analysis","volume":"66","author":"Mercadante","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/pho.2016.4104","article-title":"Low-Level Laser for Mitigation of Low Salivary Flow Rate in Head and Neck Cancer Patients Undergoing Radiochemotherapy: A Prospective Longitudinal Study","volume":"34","author":"Gonnelli","year":"2016","journal-title":"Photomed. Laser Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2015.03.017","article-title":"Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients","volume":"115","author":"Jaguar","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41241-017-0037-5","article-title":"Clinical features and preventive therapies of radiation-induced xerostomia in head and neck cancer patient: A literature review","volume":"37","author":"Jaguar","year":"2017","journal-title":"Appl. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2354.2005.00587.x","article-title":"A double-blind, crossover study of Biot\u00e8neOralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia","volume":"14","author":"Shahdad","year":"2005","journal-title":"Eur. J. Cancer Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5005\/jp-journals-10029-1062","article-title":"Efficacy of BioXtra Spray and Mouthwash in Patients with Radiation-induced Xerostomia: A Randomized Clinical Trial","volume":"3","author":"Bakhshi","year":"2014","journal-title":"Int. J. Exp. Dent. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2310\/7070.2005.04008","article-title":"Taste function in xerostomia before and after treatment with a saliva substitute containing carboxymethylcellulose","volume":"34","author":"Temmel","year":"2005","journal-title":"J. Otolaryngol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s005200050286","article-title":"A phase II study of Biotene in the treatment of post radiation xerostomia in patients with head and neck cancer","volume":"8","author":"Warde","year":"2000","journal-title":"Support. Care Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0300-9785(83)80048-9","article-title":"A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes","volume":"12","author":"Vissink","year":"1983","journal-title":"Int. J. Oral. Surg."},{"key":"ref_17","unstructured":"(2020, January 12). Manual de submiss\u00e3o dos dados de qualidade referente aos produtos sob investiga\u00e7\u00e3o utilizados em ensaios cl\u00ednicos- produtos biol\u00f3gicos, Available online: http:\/\/portal.anvisa.gov.br."},{"key":"ref_18","unstructured":"Minist\u00e9rio da Sa\u00fade (2012). Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Formul\u00e1rio Nacional da Farmacopeia Brasileira."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1053-4296(03)00033-X","article-title":"How should we measure and report radiotherapy-induced xerostomia?","volume":"13","author":"Eisbruch","year":"2003","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.14219\/jada.archive.2008.0353","article-title":"Measuring salivary flow","volume":"139","author":"Navazesh","year":"2008","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/hed.20464","article-title":"Brazilian-Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer","volume":"28","author":"Vartanian","year":"2006","journal-title":"Head Neck"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2004.12.076","article-title":"Dose\u2013volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy","volume":"62","author":"Blanco","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijrobp.2008.03.068","article-title":"Modeling of salivary production recovery after radiotherapy using mixed models: Determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function","volume":"73","author":"Ortholan","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentrerandomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ijrobp.2011.09.004","article-title":"Reducing xerostomia after chemo-IMRT for head-and-neck cancer: Beyond sparing the parotid glands","volume":"83","author":"Little","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function","volume":"76","author":"Deasy","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/COC.0b013e318261054e","article-title":"Submandibular gland-sparing intensity-modulated radiotherapy","volume":"37","author":"Mendenhall","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1754-4505.1992.tb00401.x","article-title":"A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction","volume":"12","author":"Epstein","year":"1992","journal-title":"Spec. Care Dentist."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00520-006-0210-y","article-title":"Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia","volume":"15","author":"Dirix","year":"2007","journal-title":"Support. Care Cancer"},{"key":"ref_31","first-page":"391","article-title":"Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia","volume":"54","author":"Tenovuo","year":"1997","journal-title":"Actaodontologica Scand."},{"key":"ref_32","first-page":"305ra147","article-title":"Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer","volume":"7","author":"Pringle","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2017.08.002","article-title":"Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life","volume":"126","author":"Hawkins","year":"2018","journal-title":"Radiother. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/2\/82\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:01:50Z","timestamp":1760104910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/2\/82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,18]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["curroncol31020082"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31020082","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,18]]}}}